0LIF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ultragenyx Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 25.35 USD -1.44% Market Closed

Market Cap: $2.4B

	Ultragenyx Pharmaceutical Inc LSE:0LIF	US
S	Stora Enso Oyj XMUN:ENUR	FI
	Mitsui & Co Ltd F:MTS1	JP
E	EDP Renovaveis SA ELI:EDPR	ES
	F5 Inc NASDAQ:FFIV	US
T	TJX Companies Inc F:TJX	US
	Dow Inc LSE:0A1S	US
	Hermes International SCA LSE:0HV2	FR
E	Expeditors International of Washington Inc DUS:EW1	US

Profitability Summary

Ultragenyx Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

91% > 83%

Negative Operating Margin

-74%

Negative 3Y Average Operating Margin

-101%

Operating Margin is Increasing

-167% > -74%

Negative Net Margin

-82%

Negative 3Y Average Net Margin

-108%

Net Margin is Increasing

-179% > -82%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-90%

Free Cash Flow Margin is Increasing

-137% > -69%

Exceptional ROE

839%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-68%

ROIC is Increasing

-93% > -62%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

91% > 83%

Negative Operating Margin

-74%

Negative 3Y Average Operating Margin

-101%

Operating Margin is Increasing

-167% > -74%